Lv45
660 积分 2022-09-05 加入
Circulating tumor DNA as a biomarker in early phase clinical trials
1天前
待确认
Practical recommendations for using ctDNA in clinical decision making
2天前
已完结
Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cells
1个月前
已完结
Peripheral T cell expansion predicts tumour infiltration and clinical response
1个月前
已完结
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
2个月前
已关闭
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
2个月前
已完结
Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector
2个月前
已完结
Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation
2个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
In vivo CAR engineering for immunotherapy
2个月前
已完结
皖公网安备34019202002308
